TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.

Slides:



Advertisements
Similar presentations
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells  Nilay Sethi, Xudong Dai, Christopher.
Advertisements

miR-133a positively regulated p53/p21 pathway.
T3 increased J7-TRα1 cell migration and proliferation both in vitro and in vivo. T3 increased J7-TRα1 cell migration and proliferation both in vitro and.
IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling  Yuan-Hua Xu, Zheng-Li Li,
Anti–4-1BB/PD-1 combination enriched CD8+ T cells in TILs
Tumor development of poorly immunogenic LLC and B16F10 cells modified to produce GM-CSF was markedly inhibited. Tumor development of poorly immunogenic.
NRP2 represses IGF-IR expression and signaling.
IFN-γ antagonizes TGF-β in vivo.
Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.
Volume 10, Issue 8, Pages (March 2015)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.
Effect of antiangiogenic TKIs and rMVA–CEA–TRICOM vaccine on tumor compactness, tight junctions, and intratumoral pressure in the MC38-CEA model. Effect.
The selective PI3K inhibitor A66 suppresses PIP3 accumulation, AKT phosphorylation at Thr308, and YAP/TAZ–regulated gene expression in PDAC cells. The.
Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in xenografted mice. Anti-CD20 CAR exPBNK significantly inhibit growth of Raji cells in.
Volume 12, Issue 4, Pages (July 2015)
Effect of expression of constitutively active CAMKK2 on AMPK activation and the cell cycle in G361 cells. Effect of expression of constitutively active.
CD8+ T cells were immunomodulated and required for the efficacy of anti–4-1BB/anti–PD-1 combination treatment. CD8+ T cells were immunomodulated and required.
Pharmacologic inhibition of eIF5A hypusination sensitizes KRas-driven tumor cells to MEK and KRas inhibition. Pharmacologic inhibition of eIF5A hypusination.
by Kelly E. Johnson, Julia R. Ceglowski, Harvey G. Roweth, Jodi A
IFN-γ antagonizes TGF-β in vivo.
CPI-444 efficacy requires CD8+ T cells and is associated with increased CD73 expression. CPI-444 efficacy requires CD8+ T cells and is associated with.
CO-1686 does not inhibit WT EGFR signaling in vivo and is active in EGFR-mutant transgenic mouse lung cancer models. CO-1686 does not inhibit WT EGFR signaling.
Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.
PTB-independent ShcA pools require Src to promote mammary tumorigenesis. PTB-independent ShcA pools require Src to promote mammary tumorigenesis. A, Src.
Epigenetic regulation of p16INK4a in human gastric cancer.
Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.
Identification of NSC as a FADD-kinase inhibitor.
The SFKs confer BRAF inhibitor resistance in BRAF-mutant melanoma cells. The SFKs confer BRAF inhibitor resistance in BRAF-mutant melanoma cells. A, phospho-protein.
BME treatment increases granzyme B expression in NK 3.3 cells.
The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.
Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.
A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.
A, TSG-6 staining in TRAMP tissue and TRAMP cell lines.
In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. A,
DNA demethylation reactivates GSN expression in gastric cancer cells.
Essential role for the overexpression of type I IFN-related genes in the improved chemotherapeutic response of Stat3−/− tumors. Essential role for the.
HMQ1611 inhibited breast tumor growth in mice.
A combination of neurotensin and insulin potently decreases YAP phosphorylation at Ser127 and Ser397 in PDAC cells. A combination of neurotensin and insulin.
Dasatinib overcomes the growth and metastatic spread of vemurafenib-resistant tumors. Dasatinib overcomes the growth and metastatic spread of vemurafenib-resistant.
Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent regulation of tumor growth. Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent.
Impact of eNOS expression and treatment with GSNO on prostate tumor growth. Impact of eNOS expression and treatment with GSNO on prostate tumor growth.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
TAMs directly contribute to tumor hypoxia.
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
PVT1 binds to the FOXM1 protein and increases its protein level by enhancing its stability. PVT1 binds to the FOXM1 protein and increases its protein level.
SAHA blocks IR-induced increase of RAD51 protein in MM cells.
Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors. Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors.
Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.
TGFβ1/Smad3 signaling suppresses IFNγ production via an E4BP4-dependent mechanism in NK-92 cells. TGFβ1/Smad3 signaling suppresses IFNγ production via.
Effects of ZOL treatment on pulmonary metastases.
RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.
Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.
TNFα-expanded MRD cells acquire the recurrence-competent phenotype.
Cabozantinib causes significant tumor cell elimination in vivo, but modest apoptosis induction in vitro. Cabozantinib causes significant tumor cell elimination.
LY elicits hyperphosphorylation of Akt.
Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.
FGFR2 amplification in primary human gastric tumors predicts for response to NVP-BGJ398. FGFR2 amplification in primary human gastric tumors predicts for.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.
Depletion of murine Dnmt proteins after 5-Aza-CdR treatment.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
NUAK1 overexpression correlates with tumor progression, lymph node infiltrates, and reduced overall survival (OS) in human colorectal cancer. NUAK1 overexpression.
Inhibition of HDACs disrupts DNMT1 association with Hsp90.
Tobacco-specific carcinogens induce methylation, DNA adducts, DNA damage, and activation of DNMT1. Tobacco-specific carcinogens induce methylation, DNA.
NSD2-mediated methylation of PTEN at K349 dictates cellular sensitivity to DNA-damaging agents. NSD2-mediated methylation of PTEN at K349 dictates cellular.
Antiangiogenic effects of PI3K inhibitor NVP-BKM120.
I3C reduces the level of Cdc25A protein in breast cancer cells.
Silencing E4BP4 abrogates the promoting effect of SMAD3 knockdown on IFNγ production in NK-92 cells. Silencing E4BP4 abrogates the promoting effect of.
GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.
Presentation transcript:

TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. A, AGS cells and HR cells were treated with CCL5 at different concentrations for 24 hours. DNMT1 expression was measured by Western blotting. Graphs below each blot show the quantification of DNMT protein. *, P < 0.05 versus untreated cells, one-way ANOVA. B, After treatment with CCL5 at the fixed dose of 10 ng/mL for the indicated times in AGS cells and HR cells. DNMT1 expression was analyzed by Western blotting and was quantified. *, P < 0.05; **, P < 0.01 versus the 0 hour time point, one-way ANOVA. C, During coculture with U937 cells for 72 hours, AGS cells and HR cells were treated with neutralizing CCL5 antibodies (α-CCL5). DNMT1 expression was analyzed by Western blotting and was quantified. *, P < 0.05; **, P < 0.01, significant differences between groups, one-way ANOVA. D, AGS and HR cells were treated with maraviroc at the indicated concentrations for 24 hours in the presence of CCL5 (10 ng/mL). DNMT1 expression was analyzed by Western blotting and was quantified. *, P < 0.05; **, P < 0.01; ***, P < 0.001, significant differences between groups, one-way ANOVA. E, AGS cells and HR cells were treated with CCL5 (10 ng/mL) for the indicated time. STAT3 phosphorylation was detected by Western blotting. F, AGS cells and HR cells were pretreated with AG490 (40 μmol/L) or maraviroc (1 μmol/L) for 1 hour followed by CCL5 treatment for 3 hours. STAT3 phosphorylation was measured by Western blotting. G, After AG490 pretreatment for 1 hour, AGS cells and HR cells were treated with CCL5 for 24 hours. DNMT1 expression was analyzed by Western blotting and was quantified. *, P < 0.05, significant differences between groups, one-way ANOVA. H (left), The mixtures of AGS cells and U937 cells were subcutaneously inoculated into nude mice. When the tumor volume reached 125 mm3, treatment with 5-AZA, PCA, or maraviroc began. Representative image of tumors dissected at the end of experiment from different treatment groups is shown. H (right), The graph depicts the growth curves of tumors receiving different treatments. **, P < 0.01; ***, P < 0.001 compared to the control group, two-way ANOVA. I (left), IHC staining of DNMT1 and GSN was performed using the tumors from different treatment groups. I (right), GSN mRNA expression was measured by qPCR in the tumors from different treatment groups. *, P < 0.05 versus the control group, one-way ANOVA. J, Schematic diagram depicts the possible mechanism whereby TAMs promote epigenetic silencing of GSN in gastric cancer cells. Hao-Chen Wang et al. Cancer Immunol Res 2017;5:885-897 ©2017 by American Association for Cancer Research